Get Flat 15% Discount on ED Drugs for orders value $70 or more
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Cipla > November 05, 2005

      Cipla beats Ranbaxy, tops sales in September

      Posted AtEconomic Times

      Ending Ranbaxy Laboratories's run as the top-selling drug maker in the domestic retail market for the last three months, Cipla has topped the retail sales chart in September. According to the market research firm ORG IMS latest figures, during September, Cipla's sales grew 15.3% from last month, garnering 4.92% in the Rs 29,000 domestic retail market. In comparison, sales of India's largest drug maker Ranbaxy Laboratories by revenue (including overseas sales), grew marginally 0.9% with a market share of 4.81%.

      Ranbaxy Laboratories has been leading the sales for the last three months - June to August. GlaxoSmithkline is in the third position. India's largest company by market capitalisation, Sun Pharma, is in the 7th position with 3.08% while Hyderabad-based Dr Reddy's Laboratories, India's second-largest company by revenue (including overseas sales), lies at the 13th spot with 2.24%.

      For the nine-month period ended September, Cipla continues to maintain the top spot having pipped Ranbaxy Laboratories in May. ORG IMS figures are arrived at by collecting sales figures from around thousands of pharma retail centres across the country. The Indian domestic market is around Rs 35,000 crore and growing at 13% annually. Retail sales account for around Rs 29,000 crore while the rest comes from institutional sales.

      In the brands section, Pfizer's multivitamin Becosules emerged as the highest selling brand in the Indian market during the September raking in Rs 1.47 crore. Last month's highest selling Cough syrup Corex, was down -18.9% from last month. Another cough syrup, Nicholas Piramal India Ltd's Phensedyl has taken the third spot. Himalaya Herbal Healthcare's liver tonic drug Liv 52, the only herbal drug in top 30 brands, is in the fourth position.

      For the nine-month period ended September, Novartis painkiller Voveran continues to retain the number 1 spot having taken over Corex recently.

      November 05, 2007


      Share this Article!

    Back to top^